Abstract
Biotechnology is considered one of the key technologies of the 21st century (European Commission 2007a). The society as a whole faces the impact of the biotechnology sector (Patzelt 2005). Biotechnology influences patients’ life by providing innovative drugs, which address previously unmet medical needs and increase life expectancy (e.g. the monoclonal antibody Herceptin for the treatment of breast cancer). This has positive impact on a nation’s welfare because people are healthier and can work longer, but also costs impact on the health care system, due to the increased prices of innovative drugs (Neyt et al. 2006). Biotechnology could also provide solutions for the wider society to challenges such as an increase of the global population, higher demand for natural resources (food, animal feed, clean water, energy) and for health services (OECD 2009a).
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 2012 Gabler Verlag | Springer Fachmedien Wiesbaden
About this chapter
Cite this chapter
Uecke, O. (2012). Introduction. In: How to Commercialise Research in Biotechnology?. Gabler Verlag. https://doi.org/10.1007/978-3-8349-4134-3_1
Download citation
DOI: https://doi.org/10.1007/978-3-8349-4134-3_1
Publisher Name: Gabler Verlag
Print ISBN: 978-3-8349-4133-6
Online ISBN: 978-3-8349-4134-3
eBook Packages: Business and EconomicsBusiness and Management (R0)